Biotech

All Articles

F 2G rears $100M for second attempt to get brand-new antifungal to market

.After F2G's initial attempt to receive a new training class of antifungal to market was actually wr...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 programs amidst earnings pressures

.Moderna has actually promised to cut R&ampD investing through $1.1 billion through 2027. The select...

Sanofi's $80M bet on Key dystrophy drug finishes in stage 3 go under

.Only 4 months after Sanofi wager $80 thousand in beforehand money on Key Therapeutics' losmapimod, ...

Oncternal share drains 60% surrounded by unemployments, test firings

.Cancer cells company Oncternal Therapies is actually folding all its own professional tests as well...

Novo Nordisk hails 'remarkable' fat burning lead for dual-acting oral medication in very early trial

.Novo Nordisk has actually raised the top on a stage 1 trial of its own dental amylin and also GLP-1...

AbbVie sues BeiGene over blood cancer medicine secret method

.Simply a couple of short weeks after succeeding an FDA Fast Track tag for its own investigational B...

Lilly supplies one-two punch along with second tranche of favorable information on weekly blood insulin applicant

.Shortly after a good data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based business is ...

BridgeBio cuts genetics therapy budget as scientific data disappoint

.BridgeBio Pharma is actually slashing its genetics treatment budget plan and also pulling back comi...

GSK submits HSV vaccine hopes after period 2 fail, delivering race to Moderna, BioNTech

.GSK's attempt to develop the initial injection for herpes simplex virus (HSV) has actually ended in...